KALA BIO Statistics

Total Valuation

KALA BIO has a market cap or net worth of $40.45 million. The enterprise value is $28.28 million.

Market Cap	40.45M
Enterprise Value	28.28M

Important Dates

The next estimated earnings date is Friday, March 28, 2025, before market open.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

KALA BIO has 6.09 million shares outstanding. The number of shares has increased by 53.04% in one year.

Current Share Class	6.09M
Shares Outstanding	6.09M
Shares Change (YoY)	+53.04%
Shares Change (QoQ)	+52.71%
Owned by Insiders (%)	3.40%
Owned by Institutions (%)	15.61%
Float	3.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.46
P/TBV Ratio	5.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.15, with a Debt / Equity ratio of 5.40.

Current Ratio	2.15
Quick Ratio	2.06
Debt / Equity	5.40
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.88

Financial Efficiency

Return on equity (ROE) is -430.96% and return on invested capital (ROIC) is -55.26%.

Return on Equity (ROE)	-430.96%
Return on Assets (ROA)	-43.75%
Return on Invested Capital (ROIC)	-55.26%
Return on Capital Employed (ROCE)	-133.44%
Revenue Per Employee	n/a
Profits Per Employee	-$906,116
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.39% in the last 52 weeks. The beta is -2.04, so KALA BIO's price volatility has been lower than the market average.

Beta (5Y)	-2.04
52-Week Price Change	-7.39%
50-Day Moving Average	7.58
200-Day Moving Average	6.63
Relative Strength Index (RSI)	39.29
Average Volume (20 Days)	108,077

Short Selling Information

The latest short interest is 159,301, so 2.62% of the outstanding shares have been sold short.

Short Interest	159,301
Short Previous Month	14,863
Short % of Shares Out	2.62%
Short % of Float	4.58%
Short Ratio (days to cover)	2.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-40.32M
Pretax Income	-38.72M
Net Income	-38.96M
EBITDA	-40.06M
EBIT	-40.32M
Earnings Per Share (EPS)	-$11.81

Full Income Statement

Balance Sheet

The company has $49.20 million in cash and $37.04 million in debt, giving a net cash position of $12.16 million or $2.00 per share.

Cash & Cash Equivalents	49.20M
Total Debt	37.04M
Net Cash	12.16M
Net Cash Per Share	$2.00
Equity (Book Value)	6.86M
Book Value Per Share	1.49
Working Capital	27.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.48 million and capital expenditures -$146,000, giving a free cash flow of -$32.63 million.

Operating Cash Flow	-32.48M
Capital Expenditures	-146,000
Free Cash Flow	-32.63M
FCF Per Share	-$5.36

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KALA BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.04%
Shareholder Yield	-53.04%
Earnings Yield	-96.33%
FCF Yield	-80.67%

Analyst Forecast

The average price target for KALA BIO is $15.00, which is 125.90% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	125.90%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 21, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Oct 21, 2022
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2